Intratumoral hu14.18–IL-2 (IC) Induces Local and Systemic Antitumor Effects That Involve Both Activated T and NK Cells As Well As Enhanced IC Retention

hu14.18–IL-2 (IC) is an immunocytokine consisting of human IL-2 linked to hu14.18 mAb, which recognizes the GD2 disialoganglioside. Phase 2 clinical trials of i.v. hu14.18–IL-2 (i.v.-IC) in neuroblastoma and melanoma are underway and have already demonstrated activity in neuroblastoma. We showed pre...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Yang, Richard K., Kalogriopoulos, Nicholas A., Rakhmilevich, Alexander L., Ranheim, Erik A., Seo, Songwon, Kim, KyungMann, Alderson, Kory L., Gan, Jacek, Reisfeld, Ralph A., Gillies, Stephen D., Hank, Jacquelyn A., Sondel, Paul M.
Format: Artigo
Sprog:Inglês
Udgivet: AAI 2012
Fag:
Clinical Immunology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3424361/
https://ncbi.nlm.nih.gov/pubmed/22844125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1200934
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker